Staff Oncologist and Associate Professor
Hospital for Sick Children
Daniel Morgenstern is a Staff Paediatric Oncologist at Hospital for Sick Children, Toronto and Associate Professor in Paedaitrics at the University of Toronto. He originally trained and worked in the United Kingdom, primarily at Great Ormond Street Hospital in London where he was clinical lead for the neuroblastoma. Dr Morgenstern moved to SickKids, Toronto in 2016 as Director of the New Agent and Innovative Therapy (NAIT) and Therapeutic mIBG Programs, and co-lead of the neuroblastoma service. He is Medical Director of the Oncology/BMT Clinical Trials Support Unit and Head of Clinical Trials at Hospital for Sick Children. Dr Morgenstern’s clinical activities are focussed on neuroblastoma and solid tumour patients participating in early phase clinical trials. His research interests are in early phase trials and, in particular, the use of immune checkpoint inhibitors in paediatric cancers and the development of precision medicine approaches for paediatric solid tumours.
Disclosure information not submitted.
Clinical Study Design and Effective Study in Pediatric Population
Tuesday, November 11, 2025
9:30 AM - 10:00 AM CT